戻る Agenda
[V3-S6] The Near Future of Clinical Operation - ICT Leading Virtual Clinical Trial -
Session Chair(s)
Mitsuo Hayashi, MSc, RPh
Director & Head, Clinical Enablement
MSD K.K., Japan
The progress of ICT is remarkable. We are already in such a world that you can easily measure your vital sign if wearing iWatch and you can get various information quickly if speaking to a smart speaker. Clinical trials have also experienced changes due to ICT innovation. For example, RBM is a way of thinking developed by CRF changing from paper based to electronic one. However clinical trials are areas where it is still possible to make innovative approach using ICT technology. In this session, we will introduce the present situation of Virtual Clinical Trial in EU and US, and the development and challenge of Virtual Clinical Trial in Japan. We would appreciate it if you could create a world where enrollment and site visit will change dramatically by thinking about patient engagement.
Speaker(s)
Application of Mobile Health in Clinical Development
Jing Liu, MD
Parexel International Inc., Japan
Corporate VP, Regional Head, Medical Sciences, APAC
Will Decentralized Clinical Trials be the Game-changer for Drug Development? A Deep Dive into the Opportunities, Benefits, and Challenges of Patient-centric Disruptive Trials Models
Bryan McDowell, MBA, MSc
Clario, Switzerland
Vice President, eCOA Clinical Science and Consulting
Could Virtual Clinical Trial Lead Transformation for Clinical Trial in Japan? - From the Experience of Home Visit Trial -
Makiko Okamoto
Eli Lilly Japan K.K., Japan
Sr. Manager, Clinical Innovations & Business Integration, Medical Development